The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causingPseudomonas aeruginosa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causingPseudomonas aeruginosa

Published:2016-07-25 Issue:11 Volume:12 Page:2833-2846
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kinoshita Mao,Kato Hideya,Yasumoto Hiroaki,Shimizu Masaru,Hamaoka Saeko,Naito Yoshifumi,Akiyama Koichi,Moriyama Kiyoshi,Sawa Teiji

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/21645515.2016.1209280

Reference56 articles.

1. New antibiotics for bad bugs: where are we?

2. Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians

3. Respiratory infections in patients undergoing mechanical ventilation

4. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients

5. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa;npj Vaccines;2023-05-25

2. Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections;Scientific Reports;2022-01-25

3. Passive immunization with anti- chimeric protein PilQ/PilA –DSL region IgY does not protect against mortality associated with Pseudomonas aeruginosa sepsis in a rabbit model;Molecular Immunology;2022-01

4. Whole‐Cell‐Mimicking Carrier‐Free Nanovaccines Amplify Immune Responses Against Cancer and Bacterial Infection;Advanced Functional Materials;2021-11-23

5. The Case against Antibiotics and for Anti-Virulence Therapeutics;Microorganisms;2021-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3